22.12.2012 Views

Bulletin 2010/15 - European Patent Office

Bulletin 2010/15 - European Patent Office

Bulletin 2010/15 - European Patent Office

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(C07K) II.1(1)<br />

(86) EP 2005/003977 <strong>15</strong>.04.2005<br />

(87) WO 2005/100376 2005/43 27.10.2005<br />

(30) 19.04.2004 DE 102004019406<br />

(54) • 17 ALPHA-FLUOR 17 BETA-HYDROXIMI-<br />

NOMETHYL-STEROIDE, EIN VERFAHREN<br />

ZU DEREN HERSTELLUNG UND DIESE<br />

VERBINDUNG ENTHALTENDE PHARMA-<br />

ZEUTISCHE ZUSAMMENSETZUNGEN<br />

• 17ALPHA-FLUORO-17BETA-HYDROXIMI-<br />

NOMETHYL STEROIDS, A METHOD FOR<br />

PRODUCTION THEREOF AND PHARMA-<br />

CEUTICAL COMPOSITIONS COMPRISING<br />

SAID COMPOUNDS<br />

• 17ALPHA-FLUORO-17BETA-HYDROXIMI-<br />

NOMETHYL-STEROIDES, LEUR PROCEDE<br />

DE PRODUCTION, ET COMPOSITIONS<br />

PHARMACEUTIQUES LES CONTENANT<br />

(73) Bayer Schering Pharma Aktiengesellschaft,<br />

Müllerstrasse 178, 13353 Berlin, DE<br />

(72) BOTHE, Ulrich, 10551 Berlin, DE<br />

MENZENBACH, Bernd, 07743 Jena, DE<br />

DROESCHER, Peter, 99425 Weimar, DE<br />

SCHWEIKERT, Hans-Udo, 53125 Bonn, DE<br />

ELGER, Walter, 14195 Berlin, DE<br />

HILLISCH, Alexander, 42553 Velbert, DE<br />

REDDERSEN, Gudrun, 07749 Jena, DE<br />

SCHNEIDER, Birgit, 07745 Jena, DE<br />

C07K 1/00 → (51) A61K 38/00<br />

C07K 5/00 → (51) A61K 38/00<br />

(51) C07K 5/06 (11) 1 391 461 B1<br />

C07D 471/04<br />

(25) En (26) En<br />

(21) 03018280.2 (22) 08.06.1995<br />

(84) AT BE CH DE DK ES FR GB GR IE IT LI LU<br />

MC NL PT SE<br />

(43) 25.02.2004<br />

(30) 08.06.1994 US 255276<br />

(54) • Bizyklischer Lactaminhibitor des Interleukin-1-beta-konvertierenden<br />

Enzyms<br />

• Bicyclic lactam inhibitors of interleukin-1beta<br />

converting enzyme<br />

• Inhibiteurs de l'enzyme de conversion de<br />

l'interleukine-1-beta comprenant un lactame<br />

bicyclique<br />

(73) VERTEX PHARMACEUTICALS INCORPO-<br />

RATED, 130 Waverly Street, Cambridge<br />

01239-4242, Massachusetts, US<br />

(72) Dolle, Roland, King of Prussia, Pennsylvania<br />

19406, US<br />

Chaturvedula, Prasad, V., Cheshire, Connecticut<br />

06410, US<br />

Morgan-Ross, Tina, Royersford, PA 19468,<br />

US<br />

Schmidt, Stanley, J., Chester Springs,<br />

Pennsylvania 19425, US<br />

(74) Bernasconi, Jean Raymond, et al, Cabinet<br />

Lavoix 2, Place d'Estienne d'Orves, 75441<br />

Paris Cedex 09, FR<br />

(62) 95923013.7 / 0 764 167<br />

C07K 5/062 → (51) C07D 209/40<br />

C07K 7/00 → (51) A61K 38/00<br />

C07K 7/00 → (51) C12N <strong>15</strong>/12<br />

(51) C07K 14/00 (11) 1 520 859 B1<br />

A61K 38/00 C12N 9/04<br />

(25) En (26) En<br />

(21) 04030374.5 (22) 12.01.1995<br />

(84) AT BE CH DE DK ES FR GB GR IE IT LI LU<br />

MC NL PT SE<br />

(43) 06.04.2005<br />

(30) 14.01.1994 US 182248<br />

(54) • Hydrophile Signal-Oligopeptide und Verfahren<br />

der therapeutischen Anwendung<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

• Hydrophilic signal oligopeptides and<br />

methods of therapeutic use<br />

• Oligopeptides signaux hydrophiles et leurs<br />

procédés d'utilisation à des fins thérapeutiques<br />

(73) Rath, Matthias, Dr. med., Sourethweg 9,<br />

6422 PC Heerlen, NL<br />

(72) Rath, Matthias, Dr. med., 6422 PC Heerlen,<br />

NL<br />

(74) Kleiner, Christoph, et al, Kleiner Rechtsanwälte,<br />

Alexanderstrasse 3, 70184 Stuttgart,<br />

DE<br />

(62) 95908522.6 / 0 744 027<br />

C07K 14/00 → (51) A61K 38/00<br />

(51) C07K 14/035 (11) 1 440 085 B1<br />

(25) De (26) De<br />

(21) 02785166.6 (22) 07.10.2002<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR IE IT LI LU MC NL PT SE SK TR<br />

(43) 28.07.2004<br />

(86) EP 2002/011200 07.10.2002<br />

(87) WO 2003/035884 2003/18 01.05.2003<br />

(30) 18.10.2001 DE 10<strong>15</strong>2972<br />

(54) • TRANSIENTE IMMORTALISIERUNG VON<br />

ZELLEN DURCH ONKOGENPROTEINE<br />

ODER TELOMERPROTEINE<br />

• TRANSIENT IMMORTALIZATION OF<br />

CELLS BY ONCOGENIC PROTEINS OR<br />

TELOMERASE<br />

• IMMORTALISATION TRANSITOIRE DE<br />

CELLUSES PAR DES PROTEINES ONCO-<br />

GENIQUES OU TELOMERASE<br />

(73) Heart BioSystems GmbH, Im Neuenheimer<br />

Feld 583, 69120 Heidelberg, DE<br />

(72) KÜPER, Jan-Heiner, 47574 Goch, DE<br />

MEYER, Ralph, 55596 Waldböckelheim, DE<br />

MEYER-FICCA, Mirella, 55596 Waldböckelheim,<br />

DE<br />

KUHN, Anne, 72072 Tübingen, DE<br />

(74) Simandi, Claus, <strong>Patent</strong>anwalt Höhenstrasse<br />

26, 53773 Hennef / Bonn, DE<br />

(51) C07K 14/11 (11) 1 800 697 B1<br />

C07K 14/47 A61K 48/00<br />

A61K 39/00 A61K 39/145<br />

A61P 11/00 A61P 43/00<br />

(25) De (26) De<br />

(21) 07000343.9 (22) 05.06.2002<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE TR<br />

(43) 27.06.2007<br />

(30) 05.06.2001 DE 10127283<br />

(54) • Stabilisierte mRNA mit erhöhtem G/C-<br />

Gehalt für die Gentherapie<br />

• Stabilised mRNA with increased G/C-content<br />

for use in gene therapy<br />

• ARNm avec un contenu G/C augmenté<br />

pour l'utilisation dans la thérapie génique<br />

(73) CureVac GmbH, Paul-Ehrlich-Strasse <strong>15</strong>,<br />

72076 Tübingen, DE<br />

(72) von der Mülbe, Florian, 72070 Tübingen, DE<br />

Pascolo, Steve, 72072 Tübingen, DE<br />

Hoerr, Ingmar, 72070 Tübingen, DE<br />

(74) Graf von Stosch, Andreas, et al, Graf von<br />

Stosch <strong>Patent</strong>anwaltsgesellschaft mbH<br />

Prinzregentenstrasse 22, 80538 München,<br />

DE<br />

(62) 05004938.6 / 1 604 688<br />

02732752.7 / 1 392 341<br />

C07K 14/35 → (51) G01N 33/569<br />

(51) C07K 14/47 (11) 1 237 918 B1<br />

(25) En (26) En<br />

(21) 00981316.3 (22) 28.11.2000<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE TR<br />

578<br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>15</strong>/<strong>2010</strong>) 14.04.<strong>2010</strong><br />

(43) 11.09.2002<br />

(86) EP 2000/0119<strong>15</strong> 28.11.2000<br />

(87) WO 2001/040301 2001/23 07.06.2001<br />

(30) 01.12.1999 EP 99309667<br />

(54) • GEN DAS IN SCHIZOPHRENIE DEFEKT IST<br />

• A GENE, DISRUPTED IN SCHIZOPHRENIA<br />

• GENE INTERROMPU EN CAS DE SCHIZO-<br />

PHRENIE<br />

(73) N.V. Organon, Kloosterstraat 6, 5349 AB<br />

Oss, NL<br />

Medical Research Council, 20 Park Crescent<br />

London W1B 1AL, GB<br />

UNIVERSITY OF EDINBURGH, Old College,<br />

South Bridge, Edinburgh EH8 9YL, GB<br />

(72) PORTEOUS, David, Edinburgh, Central<br />

Scotland EH4 8EH, GB<br />

MILLAR, Kirsty, Edinburgh, Central Scotland<br />

EH9 1EG, GB<br />

BLACKWOOD, Douglas, Edinburgh, Central<br />

Scotland EH9 1EG, GB<br />

MUIR, Walter, John, Tweeddale, EH45, 8NA,<br />

GB<br />

(74) Kraak, Hajo, et al, N.V. Organon Global<br />

<strong>Patent</strong> Department P.O. Box 20, 5340 BH<br />

Oss, NL<br />

(51) C07K 14/47 (11) 1 309 621 B1<br />

(25) En (26) En<br />

(21) 01960881.9 (22) 09.08.2001<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE TR<br />

(43) 14.05.2003<br />

(86) GB 2001/003597 09.08.2001<br />

(87) WO 2002/014863 2002/08 21.02.2002<br />

(30) 11.08.2000 GB 0019863<br />

(54) • PRB ACETYLIERUNG DURCH P300 UND<br />

ASSAY FÜR VERBINDUNGEN DIE DIESEN<br />

PROZESS MODULIEREN<br />

• ACETYLATION OF PRB BY P300 AND<br />

ASSAY METHODS FOR COMPOUNDS<br />

WHICH MODULATE THIS PROCESS<br />

• ACETYLATION DE PRB PAR P300 ET<br />

METHODES D'ESSAI BIOLOGIQUE POUR<br />

COMPOSES MODULANT CE PROCESSUS<br />

(73) THE UNIVERSITY COURT OF THE UNIVER-<br />

SITY OF GLASGOW, University Avenue,<br />

Glasgow, Strathclyde G12 8QQ, GB<br />

(72) LA THANGUE, Nicholas Barrie, Glasgow,<br />

Strathclyde G12 8QQ, GB<br />

CHAN, Ho Man, Glasgow, Strathclyde G12<br />

8QQ, GB<br />

(74) Brasnett, Adrian Hugh, et al, Mewburn Ellis<br />

LLP 33 Gutter Lane, London EC2V 8AS, GB<br />

C07K 14/47 → (51) A01K 67/027<br />

C07K 14/47 → (51) C07K 14/11<br />

C07K 14/475 → (51) A61K 39/395<br />

C07K 14/62 → (51) C12P 21/02<br />

(51) C07K 14/705 (11) 1 406 928 B1<br />

C07K 16/28 A61K 38/17<br />

(25) En (26) En<br />

(21) 02758350.9 (22) 17.07.2002<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR IE IT LI LU MC NL PT SE SK TR<br />

(43) 14.04.2004<br />

(86) EP 2002/007945 17.07.2002<br />

(87) WO 2003/008449 2003/05 30.01.2003<br />

(30) 19.07.2001 EP 01401946<br />

(54) • NTB-A, EIN OBERFLÄCHENMOLEKÜL<br />

IMPLIZIERT IN DER AKTIVITÄT NATÜR-<br />

LICHER KILLERZELLEN (NK)<br />

• NTB-A, A SURFACE MOLECULE INVOLVED<br />

IN NATURAL KILLER CELLS ACTIVITY

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!